Tenaya Therapeutics Ratios (2020-2026) | TNYA

Ratios Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
EBT Margin (Quarter)
-8,565.33%
EBIT Margin (Quarter)
-8,917.78%
EBITDA Margin (Quarter)
-8,565.33%
Operating Margin (Quarter)
-8,917.78%
Net Margin (Quarter)
-8,565.33%
FCF Margin (Quarter)
-8,592.89%
Efficiency
Assets Average (Quarter)
244.34M322.99M297.84M268.71M241.12M252.63M262.14M233.05M207.08M181.96M177.71M174.04M151.88M130.26M131.95M133.05M113.57M125.95M141.00M
Equity Average (Quarter)
-101.24M97.58M291.11M263.81M236.48M210.10M219.85M229.39M202.68M177.41M152.15M148.80M146.09M123.30M102.73M106.12M109.61M91.35M103.07M114.73M
Invested Capital (Quarter)
-108.54M303.70M278.53M249.10M223.87M196.33M243.38M215.41M189.94M164.88M139.42M158.18M134.00M112.60M92.85M119.40M99.83M82.87M123.27M106.19M
Leverage & Solvency
Equity Ratio (Quarter)
-0.690.920.890.880.870.870.870.880.860.850.820.860.820.800.770.830.820.790.840.79
Valuation
Enterprise Value (Quarter)
-111.89M-280.46M-251.30M-210.45M-180.92M-149.45M-186.53M-147.81M-132.50M-121.75M-104.64M-122.25M-99.30M-79.47M-61.45M-88.16M-80.70M-56.31M-100.55M-80.89M
Return Ratios
Return on Sales (Quarter)
-0.86%
Return on Capital Employed (Quarter)
-24.70%-24.17%-32.59%-41.70%-52.48%-55.01%-52.79%-63.49%-71.55%-82.40%-82.77%-80.69%-90.45%-101.45%-93.15%-85.54%-96.86%-84.45%-69.12%
Return on Assets (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%
Return on Equity (Quarter)
0.00%-0.01%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%